JP2002538142A - 抗炎症、鎮痛性および抗血栓症活性を有するニトロキシ誘導体 - Google Patents

抗炎症、鎮痛性および抗血栓症活性を有するニトロキシ誘導体

Info

Publication number
JP2002538142A
JP2002538142A JP2000602215A JP2000602215A JP2002538142A JP 2002538142 A JP2002538142 A JP 2002538142A JP 2000602215 A JP2000602215 A JP 2000602215A JP 2000602215 A JP2000602215 A JP 2000602215A JP 2002538142 A JP2002538142 A JP 2002538142A
Authority
JP
Japan
Prior art keywords
formula
residue
alkyl
group
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000602215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002538142A5 (cg-RX-API-DMAC7.html
Inventor
ベネディーニ,フランチェスカ
ソルダト,ピエロ デル
Original Assignee
ニコックス エス エイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニコックス エス エイ filed Critical ニコックス エス エイ
Publication of JP2002538142A publication Critical patent/JP2002538142A/ja
Publication of JP2002538142A5 publication Critical patent/JP2002538142A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2000602215A 1999-03-02 2000-02-23 抗炎症、鎮痛性および抗血栓症活性を有するニトロキシ誘導体 Pending JP2002538142A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT99A000413 1999-03-02
IT1999MI000413A IT1308633B1 (it) 1999-03-02 1999-03-02 Nitrossiderivati.
PCT/EP2000/001454 WO2000051988A1 (en) 1999-03-02 2000-02-23 Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity

Publications (2)

Publication Number Publication Date
JP2002538142A true JP2002538142A (ja) 2002-11-12
JP2002538142A5 JP2002538142A5 (cg-RX-API-DMAC7.html) 2007-03-29

Family

ID=11382095

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000602215A Pending JP2002538142A (ja) 1999-03-02 2000-02-23 抗炎症、鎮痛性および抗血栓症活性を有するニトロキシ誘導体

Country Status (17)

Country Link
US (1) US6613784B1 (cg-RX-API-DMAC7.html)
EP (1) EP1154999B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002538142A (cg-RX-API-DMAC7.html)
KR (1) KR100614600B1 (cg-RX-API-DMAC7.html)
CN (1) CN1225459C (cg-RX-API-DMAC7.html)
AT (1) ATE428696T1 (cg-RX-API-DMAC7.html)
AU (1) AU770642B2 (cg-RX-API-DMAC7.html)
BR (1) BR0008582A (cg-RX-API-DMAC7.html)
CA (1) CA2361164A1 (cg-RX-API-DMAC7.html)
DE (1) DE60042013D1 (cg-RX-API-DMAC7.html)
ES (1) ES2324329T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0200386A3 (cg-RX-API-DMAC7.html)
IL (1) IL144686A0 (cg-RX-API-DMAC7.html)
IT (1) IT1308633B1 (cg-RX-API-DMAC7.html)
RU (1) RU2240997C2 (cg-RX-API-DMAC7.html)
WO (1) WO2000051988A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200106650B (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1288123B1 (it) 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
EP1126838A4 (en) 1998-10-30 2005-02-16 Nitromed Inc NITROSIS AND NITROSYAL NON-STEROID ANTI-INFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE
JP2003523958A (ja) 1999-12-23 2003-08-12 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−2の阻害剤、組成物ならびに使用法
US8519005B2 (en) 2000-07-27 2013-08-27 Thomas N. Thomas Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
IT1318673B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Farmaci per le disfunzioni sessuali.
IT1318674B1 (it) * 2000-08-08 2003-08-27 Nicox Sa Faramaci per l'incontinenza.
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
IT1319202B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.
CA2432642A1 (en) 2000-12-21 2002-08-08 Subhash P. Khanapure Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
ITMI20011240A1 (it) * 2001-06-13 2002-12-13 Nicox Sa Farmaci per le vasculopatie
ITMI20011307A1 (it) * 2001-06-21 2002-12-21 Nicox Sa Farmaci per l'epilessia
ITMI20011744A1 (it) * 2001-08-09 2003-02-09 Nicox Sa Farmaci per le vasculopatie
US7220749B2 (en) 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
ITMI20021399A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Inibitori della cicloossigenasi 2
ITMI20021391A1 (it) 2002-06-25 2003-12-29 Nicox Sa Nitroderivati di inibitori della cicloossigenasi-2
JP2005535642A (ja) 2002-06-28 2005-11-24 ニトロメッド インコーポレーティッド オキシムおよび/またはヒドラゾンを含有するニトロソ化および/またはニトロシル化シクロオキシゲナーゼ−2選択的阻害剤、組成物、および使用方法
JP2005539089A (ja) * 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
CA2493156A1 (en) 2002-07-29 2004-02-05 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
DK1891447T3 (da) 2005-05-23 2011-10-17 Phadia Ab Totrins laterale flowassayfremgangsmåder og -anordninger
WO2007060112A1 (en) 2005-11-23 2007-05-31 Nicox S.A. Salicylic acid derivatives
JP2007275193A (ja) * 2006-04-04 2007-10-25 Fujifilm Corp 光プローブおよび光断層画像化装置
WO2011012400A2 (en) 2009-07-28 2011-02-03 Nicox S.A. Nitric oxide releasing naproxen
AU2011243947A1 (en) 2010-04-23 2012-12-06 Piramal Enterprises Limited Nitric oxide releasing prodrugs of therapeutic agents
US9844599B2 (en) 2013-01-21 2017-12-19 Apparao Satyam Nitric oxide releasing produgs of therapeutic agents
CN105985283B (zh) * 2015-01-30 2018-08-24 安徽省新星药物开发有限责任公司 一种布洛芬吡甲酯的合成方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004484A1 (en) * 1992-08-20 1994-03-03 Corlay S.L. Nitric esters of derivatives of the 2-(2,6-di-halophenylamino)phenylacetic acid and process for their preparation
WO1995009831A1 (en) * 1993-10-06 1995-04-13 Nicox S.A. Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
WO1995030641A1 (en) * 1994-05-10 1995-11-16 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
WO1997016405A1 (en) * 1995-10-31 1997-05-09 Nicox S.A. New compounds and their compositions having anti-inflammatory and anti-thrombotic activities

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2396145A (en) 1940-12-14 1946-03-05 Pharmscia Ab Heterocyclic sulphonamido azo compounds
US2998450A (en) 1958-05-19 1961-08-29 Warner Lambert Pharmaceutical Process of preparing nu-acetyl-p-amino phenol
GB971700A (en) 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
AT290523B (de) 1962-01-05 1971-06-11 Merck & Co Inc Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
GB1091403A (en) 1964-01-24 1967-11-15 Boots Pure Drug Co Ltd Therapeutically active phenylalkane derivatives
US3558690A (en) 1965-04-08 1971-01-26 Gelgy Chemical Corp Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation
US3337570A (en) 1965-10-23 1967-08-22 Schering Corp Substituted nicotinic acids and method for the manufacture thereof
US3904682A (en) 1967-01-13 1975-09-09 Syntex Corp 2-(6{40 -Methoxy-2{40 -naphthyl)acetic acid
FR1546478A (fr) 1967-01-27 1968-11-22 Rhone Poulenc Sa Nouveaux dérivés de l'acide benzoyl-3 phénylacétique et leur préparation
GB1195628A (en) 1967-07-26 1970-06-17 Mcneilab Inc Aroyl-Substituted Pyrroles
US3652589A (en) 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
US3600437A (en) 1969-05-28 1971-08-17 Lilly Co Eli Substituted phenylalkanoic acids and derivatives thereof
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3689653A (en) 1970-07-06 1972-09-05 Schering Corp Compositions and methods for treating inflammation using substituted nicotinic acids
US3784701A (en) 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
US3843681A (en) 1971-06-01 1974-10-22 American Home Prod 1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives
GB1403487A (en) 1972-07-21 1975-08-28 Yoshitomi Pharmaceutical Heterocyclic substituted alkanoic acids and derivatives
US3896145A (en) 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
US4035376A (en) 1972-10-24 1977-07-12 Janssen Pharmaceutica N.V. Aroyl-substituted phenylacetic acid derivatives
US3997669A (en) 1972-12-26 1976-12-14 Ciba-Geigy Corporation Tertiary aminoacids
US4061779A (en) 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
IL47877A (en) 1974-08-26 1978-10-31 Sparamedica Ag Thienothiazine carboxamide derivatives,their manufacture and pharmaceutical compositions containing them
US4089969A (en) 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4161538A (en) 1977-04-05 1979-07-17 Sankyo Company Limited Substituted phenylacetic acid derivatives and process for the preparation thereof
JPS5432460A (en) 1977-08-16 1979-03-09 Sankyo Co Ltd Cycloalkylidenemethylphenylacetic acid derivative and their preparation
AU518216B2 (en) 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPS54122284A (en) 1978-02-17 1979-09-21 Dainippon Pharmaceut Co Ltd Dibenzb,foxepin derivative
JPS5553282A (en) 1978-10-17 1980-04-18 Nippon Chemiphar Co Ltd Dibenzothiepin derivative and its preparation
CA1128526A (en) 1979-10-05 1982-07-27 Cdc Life Sciences Inc. 3,4-diarylisoxazol-5-acetic acids
SE8002321L (sv) 1980-03-26 1981-09-27 Pharmacia Ab Sett och mellanprodukter for framstellning av bensoesyraderivat
DE3049405A1 (de) 1980-12-23 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue derivate von antiphlogistisch wirksamen carbonsaeuren, ihre herstellung und medizinische anwendung
US4551452A (en) 1983-12-21 1985-11-05 Pfizer Inc. Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
US4556672A (en) 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
IE59728B1 (en) 1986-03-11 1994-03-23 American Home Prod Substituted 1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acids
IT1243367B (it) 1990-07-26 1994-06-10 Italfarmaco Spa Derivati acidi benzoici sostituiti ad attivita' cardiovascolare
GB2283238B (en) 1993-10-06 1997-11-26 Hct Health Care Trading Ltd Nitric esters of derivatives of propionic acid and process for their preparation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004484A1 (en) * 1992-08-20 1994-03-03 Corlay S.L. Nitric esters of derivatives of the 2-(2,6-di-halophenylamino)phenylacetic acid and process for their preparation
WO1995009831A1 (en) * 1993-10-06 1995-04-13 Nicox S.A. Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
WO1995030641A1 (en) * 1994-05-10 1995-11-16 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
WO1997016405A1 (en) * 1995-10-31 1997-05-09 Nicox S.A. New compounds and their compositions having anti-inflammatory and anti-thrombotic activities

Also Published As

Publication number Publication date
HUP0200386A3 (en) 2002-11-28
EP1154999B1 (en) 2009-04-15
AU770642B2 (en) 2004-02-26
HUP0200386A2 (en) 2002-06-29
ATE428696T1 (de) 2009-05-15
ES2324329T3 (es) 2009-08-05
RU2240997C2 (ru) 2004-11-27
ITMI990413A1 (it) 2000-09-02
EP1154999A1 (en) 2001-11-21
WO2000051988A1 (en) 2000-09-08
AU3158800A (en) 2000-09-21
IT1308633B1 (it) 2002-01-09
ZA200106650B (en) 2002-11-13
BR0008582A (pt) 2002-02-13
DE60042013D1 (de) 2009-05-28
US6613784B1 (en) 2003-09-02
KR100614600B1 (ko) 2006-08-25
CN1225459C (zh) 2005-11-02
CA2361164A1 (en) 2000-09-08
CN1342147A (zh) 2002-03-27
IL144686A0 (en) 2002-06-30
KR20010103782A (ko) 2001-11-23

Similar Documents

Publication Publication Date Title
KR100614600B1 (ko) 항염증성, 진통성 및 항혈전 활성을 갖는 니트록시 유도체
EP0759899B1 (en) Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
TWI268925B (en) 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
JP2001514244A (ja) 5−アルキル−2−アリールアミノフェニル酢酸および誘導体
HUP0003644A2 (hu) 2,3-Diaril-pirazolo[1,5-b]piridazin-származékok, ezeket tartalmazó gyógyászati készítmények ciklooxigenáz 2(COX-2) gátlására, valamint eljárás a vegyületek előállítására
CN101506161A (zh) 具有快速皮肤穿透速度的带正电荷的水溶性的芳基和杂芳基丙酸类前药
US20070060544A1 (en) 4-Nitro-2-[(4'-methoxy)-phenoxy]-methanesulfonanilide derivatives and their pharmaceutical use
KR900006118B1 (ko) 4-퀴놀론 유도체의 제법
JP4261639B2 (ja) フェニルイミダゾール系抗高脂血症薬
JP2002520404A (ja) 多環チアゾリジン−2−イリデンアミン、その調製方法および医薬としてのその使用
JP2000506543A (ja) 4―オキソブタン酸を含有する医薬組成物
JPH11506425A (ja) エチニルチアゾール誘導体
WO2001032658A1 (en) Polyazanaphthalene compound and medicinal use thereof
JPS6160656A (ja) ロイコトリエン拮抗剤
JPH0578554B2 (cg-RX-API-DMAC7.html)
JP3042915B2 (ja) 3−(1h−インダゾール−3−イル)−4−ピリジンアミンおよびその製造法
JPS6313985B2 (cg-RX-API-DMAC7.html)
JP3223193B2 (ja) インドール誘導体およびそれらを有効成分とする抗癌剤耐性克服物質
JPH037670B2 (cg-RX-API-DMAC7.html)
JP2002511451A (ja) アザシクロアルカン誘導体、その製造及び治療上の使用
JPH05331164A (ja) アンジオテンシンii拮抗性イソインドール誘導体
JPS62215524A (ja) 消炎剤
JPH07119225B2 (ja) フェノキシプロピルアミン誘導体およびこれを含有する抗潰瘍剤
JPS63216867A (ja) 糖ラクタム誘導体及びそれを含有する抗炎症剤
JPH051063A (ja) ピラゾロピリジン誘導体及びその製造法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070208

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100629

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100927

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20101004

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101221